Hemodynamic effects of adjunct arginine vasopressin to norepinephrine in septic shock: insights from a prospective multicenter registry study
Abstract Background The Surviving Sepsis Campaign guidelines suggest adding arginine vasopressin (AVP) when norepinephrine (NE) doses reach 0.25–0.50 µg/kg/min in septic shock patients. However, relying solely on a NE threshold has limitations, as other factors may be valuable in guiding AVP therapy...
保存先:
| 主要な著者: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2025-04-01
|
| シリーズ: | Annals of Intensive Care |
| 主題: | |
| オンライン・アクセス: | https://doi.org/10.1186/s13613-025-01472-w |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
